Shakespeare William 4
4 · Theseus Pharmaceuticals, Inc. · Filed Nov 7, 2023
Insider Transaction Report
Form 4
Shakespeare William
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2023-11-06$0.32/sh+251,084$80,347→ 639,408 total - Exercise/Conversion
Stock Option (right to buy)
2023-11-06−251,084→ 93,260 totalExercise: $0.32Exp: 2030-12-23→ Common Stock (251,084 underlying)
Footnotes (1)
- [F1]The options are immediately exercisable in full due to early exercise rights, subject to the issuer's right of repurchase. The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 1/48th of the options vesting monthly after November 18, 2020, subject to the Reporting Person's continuous service with the issuer.